The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Abstract
Osteoclasts, the cells that resorb bone, develop from hematopoietic precursors of the bone marrow under the control of factors produced in their microenvironment. The cytokine interleukin-6 can promote hematopoiesis and osteoclastogenesis. Interleukin-6 production by bone and marrow stromal cells is suppressed by 17β-estradiol in vitro. In mice, estrogen loss (ovariectomy) increased the number of colony-forming units for granulocytes and macrophages, enhanced osteoclast development in ex vivo cultures of marrow, and increased the number of osteoclasts in trabecular bone. These changes were prevented by 17β-estradiol or an antibody to interleukin-6. Thus, estrogen loss results in an interleukin-6-mediated stimulation of osteoclastogenesis, which suggests a mechanism for the increased bone resorption in postmenopausal osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Starnes, H. F., Pearce, M. K., Tewari, A., Yim, J. H., Zou, J. C., & Abrams, J. S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4185 · Cited by 322
Self-citationRetractedThe ovariectomized rat model of postmenopausal bone loss
Kalu, D. N. (1991) · Bone and Mineral · doi:10.1016/0169-6009(91)90124-i · Cited by 1,361
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L. B., Hart, D. M., Macdonald, E. B., & Clarke, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 952
OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATION
Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J. M., Martin, T. J., & Suda, T. (1988) · Endocrinology · doi:10.1210/endo-123-5-2600 · Cited by 933
OUTCOME FOR INFANTS OF VERY LOW BIRTHWEIGHT: SURVEY OF WORLD LITERATURE
STEWART, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92198-x · Cited by 830
Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., & Manolagas, S. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115668 · Cited by 679
Self-citationPacifici, R., Brown, C., Puscheck, E., Friedrich, E., Slatopolsky, E., Maggio, D., McCracken, R., & Avioli, L. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5134 · Cited by 555
Menopausal changes in bone remodeling.
Heaney, R. P., Recker, R. R., & Saville, P. D. (1978) · PubMed · Cited by 435
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 418
Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.
Roodman, G. D., Kurihara, N., Ohsaki, Y., Kukita, A., Hosking, D., Demulder, A., Smith, J. F., & Singer, F. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115584 · Cited by 366
Research works printed but not linked: 5
- BROXMEYER, H. E., CANCER CELLS-A MONTHLY REVIEW 3: 480 (1991).
- GRAVES, L, COMPARISON OF BONE AND PARATHYROID-HORMONE AS STIMULATORS OF OSTEOCLAST DEVELOPMENT AND ACTIVITY IN CALVARIAL CELL-CULTURES FROM NORMAL AND OSTEOPETROTIC (MI/MI) MICE, JOURNAL OF CELLULAR PHYSIOLOGY 145: 102 (1990). · doi:10.1002/jcp.1041450115
- HAWLEY, T.S., LEUKOCYTOSIS IN MICE FOLLOWING LONG-TERM RECONSTITUTION WITH GENETICALLY-MODIFIED BONE-MARROW CELLS CONSTITUTIVELY EXPRESSING INTERLEUKIN-1 ALPHA OR INTERLEUKIN-6, LEUKEMIA RESEARCH 15: 659 (1991). · DOI
- OTSUKA, T, THE EFFECTS OF INTERLEUKIN-6 AND INTERLEUKIN-3 ON EARLY HEMATOPOIETIC EVENTS IN LONG-TERM CULTURES OF HUMAN MARROW, EXPERIMENTAL HEMATOLOGY 19: 1042 (1991).
- Williams D. Connective Tissue Research in press.
Cited by
Items 101–158 of 158
Ray, A., Prefontaine, K. E., & Ray, P. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99966-7 · Cited by 301
The Molecular Pharmacology of SERMs
McDonnell, D. P. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(99)00177-0 · Cited by 299
Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF- B site
Galien, R., & Garcia, T. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2424 · Cited by 298
Refai, A. K., Textor, M., Brunette, D. M., & Waterfield, J. D. (2004) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30075 · Cited by 296
Estrogen receptors alpha and beta in bone
Khalid, A. B., & Krum, S. A. (2016) · Bone · doi:10.1016/j.bone.2016.03.016 · Cited by 291
Kalervo Väänänen, H., & Härkönen, P. L. (1996) · Maturitas · doi:10.1016/0378-5122(96)01015-8 · Cited by 293
The Pathophysiology and Treatment of Osteoporosis
Drake, M. T., Clarke, B. L., & Lewiecki, E. M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.006 · Cited by 290
How much is too much? Interleukin-6 and its signalling in atherosclerosis
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K., & Schieffer, B. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0297 · Cited by 289
Engleman, V. W., Nickols, G. A., Ross, F. P., Horton, M. A., Griggs, D. W., Settle, S. L., Ruminski, P. G., & Teitelbaum, S. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119404 · Cited by 285
Martin-Millan, M., Almeida, M., Ambrogini, E., Han, L., Zhao, H., Weinstein, R. S., Jilka, R. L., O'Brien, C. A., & Manolagas, S. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0354 · Cited by 282
Self-citationThe expression of cytokine activity by fracture callus
Einhorn, T. A., Majeska, R. J., Rush, E. B., Levine, P. M., & Horowitz, M. C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100818 · Cited by 281
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Ishimi, Y. (1999) · Endocrinology · doi:10.1210/en.140.4.1893 · Cited by 274
Pottratz, S. T., Bellido, T., Mocharla, H., Crabb, D., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117100 · Cited by 274
Self-citationKimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., & Pacifici, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28890 · Cited by 272
Myokines: The endocrine coupling of skeletal muscle and bone
(2020) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.07.010 · Cited by 272
The role of cytokines in inflammatory bone loss
Souza, P. P. C., & Lerner, U. H. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.822766 · Cited by 269
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
Axmann, R., Böhm, C., Krönke, G., Zwerina, J., Smolen, J., & Schett, G. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24781 · Cited by 263
Interleukin-6 prevents dexamethasone-induced myeloma cell death
Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H., & Epstein, J. (1994) · Blood · doi:10.1182/blood.v84.9.3063.3063 · Cited by 262
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
CIOCCA, D. R., & VARGAS ROIG, L. M. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-35 · Cited by 260
Age-Related Bone Loss: Old Bone, New Facts
Chan, G. K., & Duque, G. (2002) · Gerontology · doi:10.1159/000048929 · Cited by 260
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
Isomäki, P., & Punnonen, J. (1997) · Annals of Medicine · doi:10.3109/07853899709007474 · Cited by 260
Ray, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256
Scheidt-Nave, C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2032 · Cited by 255
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Self-citationChen, J. Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., & Gronemeyer, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07102.x · Cited by 255
Cytokines, bone remodeling, and estrogen deficiency: a 1998 update
JILKA, R. (1998) · Bone · doi:10.1016/s8756-3282(98)00077-5 · Cited by 255
Self-citationBone Turnover in Prolonged Critical Illness: Effect of Vitamin D
Van den Berghe, G., Van Roosbroeck, D., Vanhove, P., Wouters, P. J., De Pourcq, L., & Bouillon, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030358 · Cited by 252
Deasy, B. M., Lu, A., Tebbets, J. C., Feduska, J. M., Schugar, R. C., Pollett, J. B., Sun, B., Urish, K. L., Gharaibeh, B. M., Cao, B., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612094 · Cited by 251
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241
Clarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
Hou, Y., Zhang, S., Wang, L., Li, J., Qu, G., He, J., Rong, H., Ji, H., & Liu, S. (2012) · Gene · doi:10.1016/j.gene.2012.09.060 · Cited by 210
Molecular mechanisms of glucocorticoid-induced osteoporosis.
Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone · doi:10.1016/s8756-3282(01)00610-x · Cited by 201
Saika, M., Inoue, D., Kido, S., & Matsumoto, T. (2001) · Endocrinology · doi:10.1210/endo.142.6.8220 · Cited by 194
Khosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191
Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand
Li, J.-Y., Tawfeek, H., Bedi, B., Yang, X., Adams, J., Gao, K. Y., Zayzafoon, M., Weitzmann, M. N., & Pacifici, R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013492108 · Cited by 186
Pelekanou, V., Kampa, M., Kiagiadaki, F., Deli, A., Theodoropoulos, P., Agrogiannis, G., Patsouris, E., Tsapis, A., Castanas, E., & Notas, G. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0914-430rr · Cited by 184
Mechanism of osteoclast mediated bone resorption—rationale for the design of new therapeutics
VAANANEN, K. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.018 · Cited by 176
Giuliani, N., Sansoni, P., Girasole, G., Vescovini, R., Passeri, G., Passeri, M., & Pedrazzoni, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00220-5 · Cited by 151
Self-citationIL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Kishimoto, T., & Kang, S. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101220-023458 · Cited by 140
Targeted Expression of Calcitonin Gene-Related Peptide to Osteoblasts Increases Bone Density in Mice
Ballica, R., Valentijn, K., Khachatryan, A., Guerder, S., Kapadia, S., Gundberg, C., Gilligan, J., Flavell, R. A., & Vignery, A. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1067 · Cited by 133
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citationEstrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A. (2001) · The FASEB Journal · doi:10.1096/fj.00-0398com · Cited by 115
Zhou, J., Ye, S., Fujiwara, T., Manolagas, S. C., & Zhao, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478750 · Cited by 88
Self-citationA bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939670 · Cited by 87
Kanatani, M., Sugimoto, T., Sowa, H., Kobayashi, T., Kanzawa, M., & Chihara, K. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20041 · Cited by 74
Blaschke, M., Koepp, R., Cortis, J., Komrakova, M., Schieker, M., Hempel, U., & Siggelkow, H. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/67561 · Cited by 73
Hofbauer, L., Hicok, K., Chen, D., & Khosla, S. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470269 · Cited by 72
Tsangari, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., & Fazzalari, N. L. (2004) · Bone · doi:10.1016/j.bone.2004.02.006 · Cited by 69
Yoneda, T., Ishimaru, N., Arakaki, R., Kobayashi, M., Izawa, T., Moriyama, K., & Hayashi, Y. (2004) · Endocrinology · doi:10.1210/en.2003-1536 · Cited by 60
Estrogens: Two nuclear receptors, multiple possibilities
Biason-Lauber, A., & Lang-Muritano, M. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111710 · Cited by 49
“For example, repression of pro-osteoclastic cytokines, have been well documented to promote increased bone mass (Pacifici et al., 1989; Jilka et al., 1992; Weitzmann et al., 2002).”
Zhu, S., He, H., Gao, C., Luo, G., Xie, Y., Wang, H., Tian, L., Chen, X., Yu, X., & He, C. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0218 · Cited by 44
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
Liu, Z., Liu, M., Xiong, Y., Wang, Y., & Bu, X. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13864 · Cited by 39
Wang, F.-S., Wang, C.-J., Chen, Y.-J., Huang, Y.-T., Huang, H.-C., Chang, P.-R., Sun, Y.-C., & Yang, K. D. (2004) · Endocrinology · doi:10.1210/en.2003-1074 · Cited by 35
Cheng, B.-H., Chen, P.-C., Yang, Y.-H., Lee, C.-P., Huang, K.-E., & Chen, V. C. (2016) · Medicine · doi:10.1097/md.0000000000004655 · Cited by 31
Uemura, H., Yasui, T., Umino, Y., Niki, H., Takikawa, M., Saito, S., Furumoto, H., & Irahara, M. (2003) · Bone · doi:10.1016/j.bone.2003.08.001 · Cited by 7
Osteoprotegerin levels decrease in abstinent alcohol-dependent patients
Malik, P., von Gleissenthall, G., Gasser, R. W., Moncayo, R., Giesinger, J. M., & Mechtcheriakov, S. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13063 · Cited by 4
Metadata
- Authors
- Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C.
- Venue
- Science
- Published
- 1992-07-03
- Volume
- 257
- Issue
- 5066
- Pages
- 88-91
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1996028579
- Cited by
- 1,442
- References
- 26
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.